About IGEA
IGEA is a company based in Carpi (Italy) founded in 1980. IGEA has raised $3.93 million across 3 funding rounds from investors including European Union, Innogest Capital and Indaco Venture Partners. IGEA offers products and services including Biostim ®, Cliniporator ®, and I-ONE ®. IGEA operates in a competitive market with competitors including Globus Medical, RTI Surgical, Implanet, DJO Global and OMNILife Sciences, among others.
- Headquarter Carpi, Italy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Igea S.P.A.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.93 M (USD)
in 3 rounds
-
Latest Funding Round
$219.06 K (USD), Grant
Apr 01, 2020
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IGEA
IGEA offers a comprehensive portfolio of products and services, including Biostim ®, Cliniporator ®, and I-ONE ®.
Promotes healing of bone fractures and joint conditions.
Treats tumours using electroporation technology.
Supports therapy for spinal and bone-related issues.
Funding Insights of IGEA
IGEA has successfully raised a total of $3.93M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $219.06 thousand completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IGEA
IGEA has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Innogest Capital and Indaco Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in seed and early stage companies in Italy
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for IGEA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IGEA
Investment portfolio details for IGEA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IGEA
Detailed financials for IGEA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Igea Comparisons
Peer comparison for IGEA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IGEA
IGEA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Globus Medical, RTI Surgical, Implanet, DJO Global and OMNILife Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of minimally invasive products for musculoskeletal procedures
|
|
| Locked | Locked | Locked |
Develops innovative technologies for spinal and orthopedic implants and instruments.
|
|
| Locked | Locked | Locked |
Orthopedic implants are developed for spine, knee, and arthroscopy procedures.
|
|
| Locked | Locked | Locked |
Orthopedic devices and pain management products are developed.
|
|
| Locked | Locked | Locked |
Hip and knee orthopedic implants are engineered, manufactured, and distributed.
|
|
| Locked | Locked | Locked |
Orthopedic implants and surgical instruments are manufactured for joint surgeries.
|
Detailed competitors of IGEA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Igea
Complete news archive for IGEA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IGEA
IGEA was founded in 1980 and raised its 1st funding round 28 years after it was founded.
IGEA is headquartered in Carpi, Italy. It is registered at Carpi, Emilia-romagna, Italy.
IGEA is a funded company, having raised a total of $3.93M across 3 funding rounds to date.
IGEA develops orthopedic medical devices to promote reparative osteogenesis and joint protection, and oncological biophysics for the treatment of solid tumors. It develops orthopedic solutions for the treatment of post-traumatic bone disorders and cartilage lesions by using non-ionizing physical energy; and oncology solutions for the treatment of solid tumors using electro-chemotherapy. The companys orthopedic products include BioStim, a bone growth stimulator to activate and enhance bone healing, OsteoBit, a device using electrical fields for bone growth stimulation, OsteoSpine, a medical device for the treatment of chronic pain in patients suffering from vertebral osteoporotic fractures, and Fast, an ultrasound medical device for the treatment of recent fractures and non-unions and I-ONE therapy, a local treatment to prevent cartilage degeneration. Its oncology products include Cliniporator, a medical device for the electroporation of tumor nodules in outpatient clinics.
IGEA's top competitors include Globus Medical, ExacTech and Implanet.
IGEA offers Biostim ®, Cliniporator ®, and I-ONE ®.
IGEA has 3 investors. Key investors include European Union, Innogest Capital, and Indaco Venture Partners.